Veracyte Inc (VCYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 16,432 | 18,257 | 18,603 | 14,675 | 13,550 |
| Cost of Goods | 6,297 | 6,515 | 6,367 | 6,301 | 6,279 |
| Gross Profit | 10,135 | 11,742 | 12,236 | 8,374 | 7,271 |
| Operating Expenses | 17,949 | 15,929 | 17,489 | 19,169 | 17,301 |
| Operating Income | -7,517 | -3,672 | -4,886 | -10,494 | -9,751 |
| Interest Expense | 800 | 806 | 799 | 785 | 367 |
| Other Income | 100 | 75 | 48 | 36 | 43 |
| Pre-tax Income | -8,217 | -4,403 | -5,637 | -11,243 | -10,075 |
| Net Income Continuous | -8,217 | -4,403 | -5,637 | -11,243 | -10,075 |
| Net Income | $-8,217 | $-4,403 | $-5,637 | $-11,243 | $-10,075 |
| EPS Basic Total Ops | -0.24 | -0.13 | -0.20 | -0.40 | -0.36 |
| EPS Basic Continuous Ops | -0.24 | -0.12 | -0.20 | -0.40 | -0.36 |
| EPS Diluted Total Ops | -0.24 | -0.13 | -0.20 | -0.40 | -0.36 |
| EPS Diluted Continuous Ops | -0.24 | -0.12 | -0.20 | -0.40 | -0.36 |
| EBITDA(a) | $-6,589 | $-2,736 | $-4,187 | $-9,817 | $-9,327 |